Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

More News From fortuneweek.com

Kremlin says Putin thanked Trump for CIA tip on bombings

Dec 17, 2017

MOSCOW — Russian President Vladimir Putin telephoned U.S. President Donald Trump Sunday to thank him for a CIA tip that helped thwart a series of bombings in St. Petersburg, the Kremlin said. During the call, the two leaders' second in three days, Putin expressed gratitude for the CIA information. The Kremlin said it allowed Russia's top domestic security agency to track down a group of suspects that planned to bomb Kazan Cathedral and other crowded sites this weekend. "The information received from the CIA proved sufficient to find and detain the criminal suspects," the Kremlin said. It added that Putin...

Flames threaten coastal communities as firefighters mourn

Dec 17, 2017

LOS ANGELES — Thousands of firefighters tried Sunday to shield coastal communities from one of the biggest wildfires in California history while a funeral procession rolled past burn-scarred hillsides in honor of one of their colleagues who was killed battling the flames. Crews cleared brush and dug containment lines above hillside neighborhoods in Santa Barbara County, taking advantage of slightly calmer winds a day after gusts fanned a flare-up that prompted more evacuations. "Everything's holding really well," fire information officer Lisa Cox said. "Thousands of homes have been saved." While gusts had eased somewhat, even lower intensity winds were still...

'The Last Jedi' opens with $220M, 2nd best weekend all-time

Dec 17, 2017

NEW YORK — "Star Wars: The Last Jedi" will happily settle for second. Rian Johnson's second installment in the third "Star Wars" trilogy rocketed to a debut of $220 million at the North American box office, according to studio estimates Sunday. That gives "The Last Jedi" the second-best opening ever, slotting in behind only its predecessor, "The Force Awakens." The Disney blockbuster became just the fourth film to open above $200 million domestically. Aside from "The Force Awakens" ($248.8 million), the others are "The Avengers" ($207.4 million) and "Jurassic World" ($208.8 million). Accounting for inflation, the debut of 2012's "The...

Exiled Italian king's remains repatriated after 70 years

Dec 17, 2017

ROME — The remains of Italy's King Victor Emmanuel III were repatriated from Egypt and interred in a family mausoleum Sunday in northern Italy, 71 years after Italians rejected the monarchy in a referendum and the country's royals went into exile. The return of the king who for a time backed Benito Mussolini's fascist dictatorship dismayed members of Italy's tiny Jewish community and Italians devoted to the memory of the partisan fighters who tried to free the country from fascism's grip during World War II. Draped in a flag with the House of Savoy crest, a coffin bearing the king's...

Israel to probe fatal shooting of Palestinian paraplegic

Dec 17, 2017

GAZA CITY, Gaza Strip — The Israeli military said Sunday it has opened an investigation into the fatal shooting of a paraplegic Palestinian man who was shot in the head during a violent demonstration in the Gaza Strip last week. Ibrahim Abu Thraya, 29, was shot while demonstrating along Gaza's border with Israel, Palestinian health officials said, during days of unrest sparked by President Donald Trump's recognition of Jerusalem as Israel's capital earlier this month. Abu Thraya is being hailed as a hero and his death has emerged as a rallying cry among Palestinians against Trump's dramatic declaration, which they...